Polymyositis and Dermatomyositis

• Advances in JDM: biomarker and MRI sensitivity, outcomes and steroid management in a Dutch national prospective cohort

  2025 Lara D. Veeken article Medicine Inflammatory Myopathies and Dermatomyositis Open access

  5

  citations
• Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy

  2025 Lara D. Veeken article Medicine Inflammatory Myopathies and Dermatomyositis Open access

  6

  citations
• Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis

  2024 Journal of Autoimmunity article Medicine Inflammatory Myopathies and Dermatomyositis Open access

  9

  citations
• Using multi-parametric quantitative MRI to screen for cardiac involvement in patients with idiopathic inflammatory myopathy

  2022 Scientific Reports article Medicine Inflammatory Myopathies and Dermatomyositis Open access

  15

  citations
• Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response

  2021 Lara D. Veeken article Medicine Inflammatory Myopathies and Dermatomyositis Open access cited by 1 patent

  59

  citations
• Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependency

  2020 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access

  5

  citations
• Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis

  2020 Arthritis & Rheumatology article Medicine Inflammatory Myopathies and Dermatomyositis Open access

  43

  citations

7 results